HHS Reexamining Drug Discount Program After Rebate Plan Paused

The US Health Resource and Services Administration plans to take a deeper look at actions occurring under a federal drug discount program after its proposal to shift to a rebate system was paused.

The HRSA, an agency under the US Department of Health and Human Services that oversees the 340B Drug Pricing Program, is taking another swing at implementing a rebate system under the federal plan after sending a second proposal to the Office of Management and Budget late last week.

An agency official said Tuesday that the government is interested in understanding how revenue is being used by ...